Clinical Trials Directory

Trials / Unknown

UnknownNCT03172286

Radiofrequency Technic's Impact on Perineal Postpartum Pain

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
62 (estimated)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

A study in the postpartum period reveals that among women who delivered vaginally and having perineal lesions, between 95 and 100% of them suffer from perineal pain (episiotomy, tears from 1st to 4th degree) to 24 hours of vaginal delivery; and between 60 and 91% 7 days after delivery. Severe pain that is not taken into account can become chronic pain. It has physical and psychological consequences. It is therefore essential to prevent these risks in young mothers. The main objective of this study is to assess the efficacy of radiofrequency treatment on perineal pain postpartum, after a vaginal delivery, instrumented or not, in patients with perineal lesions. A double-blind randomized prospective single-center study will be conducted on patients delivering at Marseille's north hospital. Women who gave birth to the North hospital site, with perineal lesions (tears, episiotomy) will be invited to enroll in the study. Patients will be then randomized into two groups, one with radiofrequency treatment, the other without treatment with radiofrequency. The duration of inclusion is provided over 6 months. Each topic will be followed over a period of 1 month. The total study duration is 7 months. The expected results are a significant reduction in pain scores during the first days postpartum in women with perineal alteration caused by a vaginal delivery instrumented or not. Also an improvement in the quality of life of patients during the first days.

Conditions

Interventions

TypeNameDescription
DEVICERadiofrequencerPatients will be treated with a radiofrenquencer switched on or off depending on the attributed group after randomization

Timeline

Start date
2017-04-10
Primary completion
2018-04-01
Completion
2018-12-31
First posted
2017-06-01
Last updated
2017-06-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03172286. Inclusion in this directory is not an endorsement.